GSK3B and Alzheimer disease: Nonetheless, we found significantly lower levels of total GSK3β protein in the brains of nondiabetic AD cases, suggesting that impaired IR signaling mechanisms might contribute to the onset and/or progression of AD dementia in the absence of diabetes.